Disclosure statement
No potential conflict of interests was reported by the authors.
Additional information
Funding
This research was supported by a grant from the German Research Foundation [DFG; SFB854].
Leukemia & Lymphoma
Volume 61, 2020 - Issue 1
Letter to the Editor
Dose reduction and high-risk disease as risk factors for early death in primary CNS lymphoma
Vanja ZeremskiDepartment of Hematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany; ;Health Campus Immunology, Infectiology and Inflammation (GC-I³), Medical Center, Otto-von-Guericke University, Magdeburg, GermanyCorrespondence[email protected]
http://orcid.org/0000-0002-5254-9885View further author information
http://orcid.org/0000-0002-5254-9885View further author information, & ![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})